Insights
Where genetics meets litigation.
Short, practical pieces on the science behind product liability and life sciences cases — written in plain terms for lawyers. New writing is on the way.
Published · Aug 2026
The Duty to Warn in the Age of Pharmacogenomics
How the Plavix litigation brings genetic susceptibility, pharmacogenomics, and the pharmaceutical duty to warn into product liability strategy.
Forthcoming
Foreign companies in U.S. discovery
What to prepare, what surprises Japanese companies most, and what AI is beginning to change about review and translation.
Forthcoming
Reading the genome as evidence
A plain-language primer for litigators on what genomic data can and cannot establish in court.
Forthcoming
IPR vs. PGR: a scientist's view
How the underlying science should shape the choice of proceeding before the USPTO.
Want to know when these publish, or discuss a topic? Get in touch.